In addition, the hippocampal FGF21 level was not different among the groups, but AME supplementation enhanced the protein levels of FGFR1 and β-klotho, which determines the sensitivity of organ-to-FGF21 signaling in T2DM. The gene discussed is FGFR1; the disease is type 2 diabetes mellitus.